Home
EZGO
EZGO News

Latest EZGO Technologies Ltd. (EZGO) News on June 30, 2025

EZGO Technologies Full Year 2024 Earnings: US$2.80 loss per share (vs US$5.91 loss in FY 2023)

Simply Wall St.

5 months ago

EZGO Technologies Full Year 2024 Earnings: US$2.80 loss per share (vs US$5.91 loss in FY 2023)

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2024

PR Newswire

5 months ago

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2024

MT Newswires

6 months ago

Ezgo Technologies Receives Nasdaq Deficiency Notice

EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

PR Newswire

6 months ago

EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

EZGO ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED MARCH 31, 2024

PR Newswire

10 months ago

EZGO ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED MARCH 31, 2024

EZGO Enters into a Strategic Cooperation Framework Agreement with Woteam to Jointly Explore the Southeast Asian Market

PR Newswire

a year ago

EZGO Enters into a Strategic Cooperation Framework Agreement with Woteam to Jointly Explore the Southeast Asian Market

EZGO Enters into an RMB13 Million Procurement Agreement for Sale of Security Patrol Robots and Platform

PR Newswire

a year ago

EZGO Enters into an RMB13 Million Procurement Agreement for Sale of Security Patrol Robots and Platform

EZGO Announces 1-for-40 Reverse Share Split Effective April 12, 2024

PR Newswire

a year ago

EZGO Announces 1-for-40 Reverse Share Split Effective April 12, 2024

EZGO Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

PR Newswire

a year ago

EZGO Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

USAC Announces Appointment of Jeffrey Fink as Vice President & General Manager of Bear River Zeolite ("BRZ")

ACCESSWIRE

a year ago

USAC Announces Appointment of Jeffrey Fink as Vice President & General Manager of Bear River Zeolite ("BRZ")

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023

PR Newswire

a year ago

EZGO ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023

Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

GlobeNewswire

a year ago

Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

Cosmic Gains? 3 Space Stocks Worth a Closer Look.

InvestorPlace

a year ago

Cosmic Gains? 3 Space Stocks Worth a Closer Look.

Arcutis Biotherapeutics, Inc. (ARQT) Moves to Strong Buy: Rationale Behind the Upgrade

Zacks

a year ago

Arcutis Biotherapeutics, Inc. (ARQT) Moves to Strong Buy: Rationale Behind the Upgrade

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

GlobeNewswire

a year ago

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

Los Angeles County Awards 5 Year Contract to Genasys for Evacuation Management Solution

GlobeNewswire

a year ago

Los Angeles County Awards 5 Year Contract to Genasys for Evacuation Management Solution

Analyst Approved: 3 Stocks Wall Street Insiders Are Whispering About

InvestorPlace

a year ago

Analyst Approved: 3 Stocks Wall Street Insiders Are Whispering About

SurgePays Announces Proposed Public Offering

GlobeNewswire

a year ago

SurgePays Announces Proposed Public Offering

Future FinTech CEO Denies SEC’s Manipulative-Trading Allegations

The Wall Street Journal

a year ago

Future FinTech CEO Denies SEC’s Manipulative-Trading Allegations

7 A-Rated Software Stocks to Buy in January

InvestorPlace

a year ago

7 A-Rated Software Stocks to Buy in January

Shanchun Huang Responds to SEC Allegations

PR Newswire

a year ago

Shanchun Huang Responds to SEC Allegations

CISO Global to Present at the 26th Annual Needham Growth Conference

GlobeNewswire

a year ago

CISO Global to Present at the 26th Annual Needham Growth Conference

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

ACCESSWIRE

a year ago

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Jeremy Gies Appointed to President of SurgePays, Inc.

GlobeNewswire

a year ago

Jeremy Gies Appointed to President of SurgePays, Inc.

MARPAI HIRES JOHN POWERS AS PRESIDENT

PR Newswire

a year ago

MARPAI HIRES JOHN POWERS AS PRESIDENT

Fury Reviews 2023 Achievements and Appoints CFO

ACCESSWIRE

a year ago

Fury Reviews 2023 Achievements and Appoints CFO

Cepton Sets New Industry Benchmark with Next-Generation Flagship Automotive Lidar, Ultra

Business Wire

a year ago

Cepton Sets New Industry Benchmark with Next-Generation Flagship Automotive Lidar, Ultra

SatixFy to Participate at the 26th Annual Needham Growth Conference

Business Wire

a year ago

SatixFy to Participate at the 26th Annual Needham Growth Conference

MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024

Business Wire

a year ago

MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024

ACCESSWIRE

a year ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Genasys to Present at Leading Investor Conferences

GlobeNewswire

a year ago

Genasys to Present at Leading Investor Conferences

Microbot Medical (MBOT) Announces Positive GLP Study Results

Zacks

a year ago

Microbot Medical (MBOT) Announces Positive GLP Study Results

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate

Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results

GlobeNewswire

2 years ago

Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

GlobeNewswire

2 years ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Fujian Blue Hat Interactive Entertainment Technology First Half 2023 Earnings: US$0.36 loss per share (vs US$1.02 loss in 1H 2022)

Simply Wall St.

2 years ago

Fujian Blue Hat Interactive Entertainment Technology First Half 2023 Earnings: US$0.36 loss per share (vs US$1.02 loss in 1H 2022)

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

GlobeNewswire

2 years ago

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

GlobeNewswire

2 years ago

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

Austin Gold Corporate Update

Newsfile

2 years ago

Austin Gold Corporate Update

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

GlobeNewswire

2 years ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Modular Medical Announces Collaboration with Glooko

ACCESSWIRE

2 years ago

Modular Medical Announces Collaboration with Glooko

Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study

GlobeNewswire

2 years ago

Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study

3 Growth Stocks That Can Double in 2024

InvestorPlace

2 years ago

3 Growth Stocks That Can Double in 2024

PR Newswire

2 years ago

ETAO International Co. Ltd. Received Nasdaq Delisting Determination

Streamline Health Solutions Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 years ago

Streamline Health Solutions Third Quarter 2024 Earnings: Misses Expectations

Genasys Independent Director Acquires 13% More Stock

Simply Wall St.

2 years ago

Genasys Independent Director Acquires 13% More Stock

What You Need To Know About The Streamline Health Solutions, Inc. (NASDAQ:STRM) Analyst Downgrade Today

Simply Wall St.

2 years ago

What You Need To Know About The Streamline Health Solutions, Inc. (NASDAQ:STRM) Analyst Downgrade Today

GlobeNewswire

2 years ago

YanGuFang Oatmeal Tops Sales Chart in Key Category on Douyin during the Double 11 Festival in China

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Streamline Health Solutions Inc Earnings Call

Streamline Health® Announces Signing of new RevID™ Contract with 2,300-Bed Health System

GlobeNewswire

2 years ago

Streamline Health® Announces Signing of new RevID™ Contract with 2,300-Bed Health System

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study

GlobeNewswire

2 years ago

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study

Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

GlobeNewswire

2 years ago

Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

GlobeNewswire

2 years ago

Brad Jacobs to Enter Building Products Distribution Industry

Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023

GlobeNewswire

2 years ago

Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

GlobeNewswire

2 years ago

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

News Direct

2 years ago

ZeroFox announces record annual recurring revenue as company shares Q3 financials

XPO's Brad Jacobs talks SilverSun acquisition, equity growth

Yahoo Finance Video

2 years ago

XPO's Brad Jacobs talks SilverSun acquisition, equity growth

ZeroFox Holdings, Inc. (NASDAQ:ZFOX) Q3 2024 Earnings Call Transcript

Insider Monkey

2 years ago

ZeroFox Holdings, Inc. (NASDAQ:ZFOX) Q3 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2024 ZeroFox Holdings Inc Earnings Call

ZeroFox Holdings, Inc. (ZFOX) Reports Q3 Loss, Tops Revenue Estimates

Zacks

2 years ago

ZeroFox Holdings, Inc. (ZFOX) Reports Q3 Loss, Tops Revenue Estimates

Jacobs leading takeover of software company as he readies next move

FreightWaves

2 years ago

Jacobs leading takeover of software company as he readies next move

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of November 30, 2023, for TYG, NTG, TTP, NDP and TPZ

ACCESSWIRE

2 years ago

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of November 30, 2023, for TYG, NTG, TTP, NDP and TPZ

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Zacks

2 years ago

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

SAB Biotherapeutics Starts Human Clinical Trial of Diabetes Treatment

Exec Edge

2 years ago

SAB Biotherapeutics Starts Human Clinical Trial of Diabetes Treatment

Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement

PR Newswire

2 years ago

Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement

YanGuFang Expands Retail Presence in China's Supermarkets

GlobeNewswire

2 years ago

YanGuFang Expands Retail Presence in China's Supermarkets

Creative Media & Community Trust Corporation (NASDAQ:CMCT) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Creative Media & Community Trust Corporation (NASDAQ:CMCT) Q3 2023 Earnings Call Transcript

Palatin Technologies, Inc. (AMEX:PTN) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Palatin Technologies, Inc. (AMEX:PTN) Q1 2024 Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks

2 years ago

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After Plunging -28.72% in 4 Weeks, Here's Why the Trend Might Reverse for Trevi Therapeutics, Inc. (TRVI)

Zacks

2 years ago

After Plunging -28.72% in 4 Weeks, Here's Why the Trend Might Reverse for Trevi Therapeutics, Inc. (TRVI)

EZGO Completes Delivery of Premium E-bicycles Transactions Valued RMB12 Million

PR Newswire

2 years ago

EZGO Completes Delivery of Premium E-bicycles Transactions Valued RMB12 Million

Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

PR Newswire

2 years ago

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023

Business Wire

2 years ago

Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023

CXApp Inc. (Nasdaq:CXAI) Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

ACCESSWIRE

2 years ago

CXApp Inc. (Nasdaq:CXAI) Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

Full House Resorts Announces Strong Third Quarter Results

GlobeNewswire

2 years ago

Full House Resorts Announces Strong Third Quarter Results

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Associated Press Finance

2 years ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

PR Newswire

2 years ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

Aware, Inc. (NASDAQ:AWRE) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Aware, Inc. (NASDAQ:AWRE) Q3 2023 Earnings Call Transcript

Vincerx Pharma To Present Three Posters at ASH 2023 in December

GlobeNewswire

2 years ago

Vincerx Pharma To Present Three Posters at ASH 2023 in December

Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023

PR Newswire

2 years ago

Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023

Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment

Business Wire

2 years ago

Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment

Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer

Business Wire

2 years ago

Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer

Share on Social Networks: